Tag - alzheimers

 
 

ALZHEIMERS

Japan Times
WORLD / Science & Health
Apr 19, 2022
Scientists question data behind an experimental Alzheimer’s drug
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
Japan Times
BUSINESS
Apr 9, 2022
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
COMMENTARY / World
Mar 17, 2022
The silver lining hidden in the battle against long COVID
Long COVID-19 research could reveal clues to help fight Alzheimer's, Lyme Disease and other illnesses.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD
Sep 3, 2021
Lawmakers probe ‘anomalies’ in approval of Biogen Alzheimer’s drug
The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency's decision.
Japan Times
COMMENTARY / World
Jul 19, 2021
Latest U.S. Alzheimer's drug fix is a patch job
Most of the FDA's decisions don't receive national attention, which means they may not be rectified until substantial harm is done.
Japan Times
BUSINESS / Companies
Jul 13, 2021
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first
The U.S. Food and Drug Administration's June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn't deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug 'accelerated approval.”
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
BUSINESS
Dec 6, 2019
Biogen builds case for its Alzheimer's drug, but skeptics say more data needed
Biogen Inc. laid out more data Thursday on its experimental Alzheimer's drug, raising no major safety alarms but also offering little compelling evidence that the drug, once declared a failure, actually works.
JAPAN / Science & Health
Nov 6, 2019
Japanese researchers pave way for early diagnosis of Alzheimer's using blood test
A team of researchers from Nagoya City University and other institutions have discovered a method that may pave the way for early diagnosis of Alzheimer's disease using a blood test.
Japan Times
BUSINESS
Oct 23, 2019
Biogen and Eisai revive plans for Alzheimer's drug aducanumab, but prospects still shaky
Biogen Inc. revived plans on Tuesday to seek U.S. approval for the Alzheimer's treatment aducanumab and said data from more patients in two discontinued studies showed the drug reduced the decline of patients.
Japan Times
CULTURE / Film
May 29, 2019
'A Long Goodbye': Taking a lighter look at Alzheimer's
Japanese films about dementia are by now many and, given demographic trends here, interest in the subject is both natural and necessary.
Japan Times
WORLD / Science & Health
Apr 9, 2019
Zap cap: Electrical brain stimulation seen boosting memory function in older people
Electrical brain stimulation using a noninvasive cap can help boost older people's mental scores to those of people 20 to 30 years younger, according to a study published on Monday.
Japan Times
ASIA PACIFIC / Science & Health
Sep 27, 2018
Scientists look to Chinese soup ingredients to treat dementia
The ingredients in this experimental brain treatment may be better known to enhance cooking, not cognition.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?